January 28, 2013

Sanofi Announces Auvi-QTM, the First and Only Voice-Guided Epinephrine Auto-Injector, is Now Available in the U.S.

Breakthrough device design talks patients and caregivers through the injection process

 

Sanofi Announces Auvi-QTM, the First and Only Voice-Guided Epinephrine Auto-Injector, is Now Available in the U.S.
Breakthrough device design talks patients and caregivers through the injection process

Paris, France – January 28, 2013 – Sanofi (EURONEXT : SAN and NYSE : SNY) announced today that Auvi-QTM (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.